Michael Ristow (b April 24, 1967) is a German medical researcher who has published influential articles on biochemical aspects of mitochondrial metabolism and particularly the possibly health-promoting role of reactive oxygen species in diseases like type 2 diabetes, obesity and cancer, as well as general aging due to a process called mitohormesis. These findings bring into question Denham Harman's free radical theory of aging, and provide a mechanistic basis to question the application of antioxidants to human health.

Property Value
dbo:abstract
  • Michael Ristow (* 24. April 1967 in Lübeck) ist ein deutscher Arzt (Internist) und Wissenschaftler. Er ist tätig als Professor für Energiestoffwechsel an der ETH Zürich mit dem Forschungsgebiet des mitochondrialen Stoffwechsels und seiner möglichen Bedeutung für die Entstehung von Krankheiten wie Diabetes mellitus Typ 2 (Zuckerkrankheit), Übergewicht und Krebs, sowie dessen Bedeutung bei allgemeiner Alterung. (de)
  • Michael Ristow (b April 24, 1967) is a German medical researcher who has published influential articles on biochemical aspects of mitochondrial metabolism and particularly the possibly health-promoting role of reactive oxygen species in diseases like type 2 diabetes, obesity and cancer, as well as general aging due to a process called mitohormesis. Ristow was born in Lübeck in the North of Germany. He graduated at the University of Bochum in 1992 and received his M.D. from University of Bochum in 1996. He was appointed to the University of Jena in 2005 as a full professor in nutritional science, and is a full professor in energy metabolism at the ETH Zurich since 2013. In 2007, Ristow’s group published evidence which could explain the basis of the observed extension of lifespan by restriction of sugar intake. In experiments on a model organism, the worm Caenorhabditis elegans, they found that lowering the availability of glucose extended the lifespan of the worms. It has been known since the 1930s that restricting calories while maintaining adequate amounts of other nutrients extends lifespan across a broad range of organisms. The mechanism has been proposed as a change in the activity of the sirtuins. Michael Ristow shows in his article that this effect can also occur independent of sirtuins, since worms deficient for sirtuins still show extended life span in states of sugar restriction. Most importantly, Ristow's research suggests that this is a mitohormetic effect, as reviewed in. Hormesis is a controversial concept in which it has been demonstrated that the induction of a stress can lengthen lifespan in some species. Ristow's interpretation was that in response to a decrease in glycolytic energy production, the worms have to generate ATP by oxidative phosphorylation in the mitochondria, leading to increased production of reactive oxygen species. Due to a vacination-like response, the organism produces more defenses against oxidative stress, including increased production of catalase. Supplementation with antioxidants abolishes the increase in lifespan, and so does disruption of an AMP-kinase but not disruption of sirtuins. In a follow-up study that experienced significant media attention, Ristow and colleagues have shown that supplementing humans with antioxidants during physical exercise blocks the health-promoting effects of exercise, suggesting that free radicals produced during exercise are responsible and required for the effects of exercise. These findings bring into question Denham Harman's free radical theory of aging, and provide a mechanistic basis to question the application of antioxidants to human health. In earlier years, Ristow published a seminal article describing a genetic mutation associated with extreme human obesity. Ristow’s laboratory has provided direct evidence supporting the so-called Warburg hypothesis. Specifically Ristow has shown that forced metabolic activity and respiration of mitochondria efficiently blocks cancer growth as anticipated by Otto Heinrich Warburg as early as in 1924. Independent of his work on oxidative stress, Ristow has recently shown that increased concentrations of the trace metal Lithium contained in drinking water are associated with increased lifespan in Japan suggesting a readily available anti-aging intervention. (en)
dbo:almaMater
dbo:birthDate
  • 1967-04-24 (xsd:date)
  • 1967-1-1
dbo:birthPlace
dbo:field
dbo:knownFor
dbo:nationality
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 12438132 (xsd:integer)
dbo:wikiPageRevisionID
  • 723537465 (xsd:integer)
dbp:workInstitutions
  • ETH Zurich, Switzerland
  • Harvard University, Cambridge
  • Joslin Diabetes Center, Boston
  • University of Cologne, Germany
  • University of Jena, Germany
dct:description
  • German physician (en)
dct:subject
http://purl.org/linguistics/gold/hypernym
rdf:type
rdfs:comment
  • Michael Ristow (* 24. April 1967 in Lübeck) ist ein deutscher Arzt (Internist) und Wissenschaftler. Er ist tätig als Professor für Energiestoffwechsel an der ETH Zürich mit dem Forschungsgebiet des mitochondrialen Stoffwechsels und seiner möglichen Bedeutung für die Entstehung von Krankheiten wie Diabetes mellitus Typ 2 (Zuckerkrankheit), Übergewicht und Krebs, sowie dessen Bedeutung bei allgemeiner Alterung. (de)
  • Michael Ristow (b April 24, 1967) is a German medical researcher who has published influential articles on biochemical aspects of mitochondrial metabolism and particularly the possibly health-promoting role of reactive oxygen species in diseases like type 2 diabetes, obesity and cancer, as well as general aging due to a process called mitohormesis. These findings bring into question Denham Harman's free radical theory of aging, and provide a mechanistic basis to question the application of antioxidants to human health. (en)
rdfs:label
  • Michael Ristow (de)
  • Michael Ristow (en)
owl:sameAs
prov:wasDerivedFrom
foaf:gender
  • male (en)
foaf:givenName
  • Michael (en)
foaf:isPrimaryTopicOf
foaf:name
  • Michael Ristow (en)
foaf:surname
  • Ristow (en)
is dbo:wikiPageDisambiguates of
is foaf:primaryTopic of